Skip to main content
Clinical Trials/CTRI/2023/10/058245
CTRI/2023/10/058245RecruitingPhase 2/3

A single blind randomized comparative clinical study to evaluate the efficacy of Eranda saptaka kwatha and Rasonadi kwatha in the management of Stabdhata and Ruja associated with Amavatha.

Dr Samprath Nayak1 site in 1 country60 target enrollmentStarted: October 10, 2023Last updated:

Trial Snapshot

Phase
Phase 2/3
Status
Recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Pain

Study Overview

Brief Summary

This is a single blind randomized comparative clinical study to evaluate the effect of eranda saptaka kwatha and rasonadi kwatha for 30 days. This study comprise of two groups of 30 subjects with pain and stiffness associated with Amavata. Study will be conducted in ALN Rao memorial ayurvedic hospitals in koppa and quard hitlow places, koppa taluk, chikmagaluru distric 577126, karnataka, india. Primary out come measure will be Ruja(pain) and Stabdhata(stiffness) fin 30 days.

Study Design

Study Type
Interventional
Allocation
Permuted block randomization, fixed
Masking
Participant Blinded

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients of age group above 20 years and below 60 years
  • Patients diagnosed as Amavata on basis of Classical Lakshanas, specifically considering Stabdhata and Ruja for study.
  • Patient with controlled systemic diseases.

Exclusion Criteria

  • Patients below 20 years and above 60 years.
  • Other complicated joint disorders.
  • Complications including deformities, contractures and nodules.

Outcomes

Primary Outcomes

Pain

Time Frame: 30 days

stiffness

Time Frame: 30 days

Secondary Outcomes

  • not applicable(not applicable)

Investigators

Sponsor
Dr Samprath Nayak
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials